“…The results from these studies, often but not always replicated (Anderson et al, 1984), correlated levels of PEA, TYR, TRYP, or their metabolites in blood and/or urine with methylphenidate and AMPH exposure (Borison et al, 1975), hypertension (Andrew et al, 1993), and hepatic encephalopathy (Manghani et al, 1975) as well as mental conditions including schizophrenia (Boulton et al, 1967;Vogel, 1967;Faurbye, 1968;Zeller et al, 1976;Sandler & Reynolds, 1976;Boulton, 1980;Boulton, 1982;Szymnanski et al, 1987;Myojin et al, 1989;O'Reilly et al, 1991;O'Reilly & Davis, 1994;Buckland et al, 1997), Tourette's syndrome (Baker et al, 1993), attention deficit hyperactivity disorder (i.e. ADHD; Baker et al 1991;Kusaga, 2002), migraine (Hannington, 1967;Smith et al, 1970;Sever, 1979;D'Andrea et al, 2003b) and other headache Aridon et al, 2004), and depression Reynolds, 1979;Sandler et al, 1980;Chance et al, 1985;Davis & Boulton, 1994).…”